{"filings":[{"id":130558,"accession_number":"0001493152-25-027891","cik":73290,"company_name":"BIOMERICA INC","ticker":"BMRA","form_type":"8-K","filed_at":"2025-12-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Biomerica stockholders elect all 5 director nominees, approve share increase from 25M to 300M at 2025 annual meeting","event_type":"other_material","confidence":"high","bullets":["All five director nominees elected with majority votes: Irani, Barbieri, Bing Chin, Huff, Moatazedi.","Non-binding advisory vote on executive compensation passed (411,157 for, 87,344 against).","Ratification of Haskell & White LLP as independent auditor for FY ending May 31, 2026 approved (1,472,716 for).","Amendment to 2024 Stock Incentive Plan to increase shares by 200,000 approved (371,339 for).","Amendment to Certificate of Incorporation to increase authorized common stock from 25M to 300M approved (1,028,102 for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130557,"accession_number":"0001493152-25-017363","cik":73290,"company_name":"BIOMERICA INC","ticker":"BMRA","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Biomerica appoints former LabCorp Diagnostics CEO Gary Huff to board; director Emerson not standing for re-election","event_type":"leadership","confidence":"high","bullets":["Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.","Huff receives annualized cash fee of $45,000 (paid quarterly); no equity compensation granted for board appointment.","Dr. Jane Emerson to step down after 18 years on board, not seeking re-election at Dec 12, 2025 annual meeting; board size to reduce to 5.","Huff brings 35+ years of lab industry experience, having served as CEO of LabCorp Diagnostics and Baylor Genetics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165654,"accession_number":"0001641172-25-013942","cik":73290,"company_name":"BIOMERICA INC","ticker":"BMRA","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Biomerica appoints Eric Chin to board; Cathy Coste resigns effective June 4","event_type":"leadership","confidence":"high","bullets":["Cathy Coste resigned as director effective June 4, 2025; no disagreement with the company.","Eric Chin appointed as independent director and Audit Committee Chair, effective same date.","Chin is CFO of Akido Labs, helped raise $60M; will receive $41K annual cash and 10,000 restricted shares.","Chin also joins Nominating/Governance and Compensation Committees.","No family relationships or transactions requiring disclosure; board determined independent per Nasdaq rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}